Interactions of dihydropyridine Ca2+ channel agonists with the human platelet thromboxane A2/prostaglandin H2 receptor
- 25 January 1991
- journal article
- Published by Elsevier in European Journal of Pharmacology: Molecular Pharmacology
- Vol. 206 (1) , 15-21
- https://doi.org/10.1016/0922-4106(91)90141-4
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Ca2+ agonists: new, sensitive probes for Ca2+ channelsTrends in Pharmacological Sciences, 1988
- Dihydropyridine agonist Bay K 8644 inhibits platelet activation by competitive antagonism of thromboxane A2-prostaglandin H2 receptor.Circulation Research, 1988
- Evidence for the receptor-operated calcium channels in human platelet plasma membraneThrombosis Research, 1987
- Inositol 1,4,5-triphosphate-induced granule secretion in platelets. Evidence that the activation of phospholipase C mediated by platelet thromboxane receptors involves a guanine nucleotide binding protein-dependent mechanism distinct from that of thrombin.Journal of Clinical Investigation, 1987
- Agonists stimulate divalent cation channels in the plasma membrane of human plateletsFEBS Letters, 1985
- Stereoselectivity at the Calcium ChannelJournal of Cardiovascular Pharmacology, 1985
- Lack of evidence for voltage dependent calcium channels on plateletsBiochemical and Biophysical Research Communications, 1985
- Enhancement of calcium influx in human platelets by CGP 28392, a novel dihydropyridineBiochemical and Biophysical Research Communications, 1984
- The synthesis of prostaglandin endoperoxide analogsTetrahedron Letters, 1975
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973